Vantictumab (FZD) - Research Grade Biosimilar
Product Specifications
Background
Vantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.
Immunogen
Homo sapiens / FZD [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG2-lambda
NCBI Organism
Homo sapiens
Other Product Names
OMP-18R5
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740304-500 1x 500 µL
CD106 / VCAM1 (B-K9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC801037-500 1x 500 µL
CD44 Standard (DF1485), CF680 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880204-100 1x 100 µL
Complement C4d (C4D204), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040043-100 1x 100 µL
P21 / WAF1 (WA-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740174-500 1x 500 µL
CD45RB (BRA-11G), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681482-100 1x 100 µL
S100A4 (Marker of Tumor Metastasis) (S100A4/1482), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details